MYGN

Myriad Genetics, Inc.

Sağlık

COMPLIANT — All screening ratios are below the thresholds; the company is compliant with halal investment criteria.

$5.68

Price (1 Year)

$7.63 $2.86

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %10.6 / %30
Non-compliant assets / Total market cap %0 / %30
Non-compliant revenue / Total income %0.3 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Myriad Genetics, Inc., a molecular diagnostics and precision medicine company, develops molecular tests. It offers molecular diagnostic tests for oncology, women's health, and pharmacogenomics.

Website

Analysis (Turkish): MYGN Hissesi Caiz mi, Helal mi? Myriad Genetics, Inc. Katılım Analizi